Market Research

Cell Analysis Market (End-user: Biotechnology & Pharmaceutical Companies, Academia, Cosmetic Industry, Contract Research Organizations, and Contract Development & Manufacturing Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Fo

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 166 Pages Transparency Market Research Pvt. Ltd. August, 2023 TNPR18249860
Best Price Guarantee
Price from $5,795
Length 166 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date August, 2023
SKU TNPR18249860

Cell Analysis Market (End-user: Biotechnology & Pharmaceutical Companies, Academia, Cosmetic Industry, Contract Research Organizations, and Contract Development & Manufacturing Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Cell Analysis Market – Scope of Report

TMR’s report on the global cell analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global cell analysis market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell analysis market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cell analysis market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell analysis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cell analysis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell analysis market.

The report delves into the competitive landscape of the global cell analysis market. Key players operating in the global cell analysis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell analysis market profiled in this report.

Key Questions Answered in Global Cell Analysis Market Report
  • What is the sales/revenue generated by cell analysis across all regions during the forecast period?
  • What are the opportunities in the global cell analysis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Cell Analysis Market – Research Objectives and Research Approach

The comprehensive report on the global cell analysis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell analysis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell analysis market.


1. Preface
1.1. Market Definition and Scope
1.2. Key Research Objectives
2. Assumptions and Research Methodology
3. Market Overview
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Overview on R&D spending of major biotechnology and pharmaceutical companies by therapeutic area
3.3.1. Top 15 Origins of Pipeline Drugs
3.3.2. Biological versus non-biological drugs as a % of pipeline
3.3.3. Ongoing rise of gene and cell therapy
4. Global Cell Analysis Market Analysis and Forecast, by End-user
4.1. Introduction & Definition
4.2. Key Findings/Developments
4.3. Market Value Forecast, by End-user, 2017-2031
4.3.1. Biotechnology & Pharmaceutical Companies
4.3.2. Academia
4.3.3. Cosmetic Industry
4.3.4. Contract Research Organizations
4.3.5. Contract Development and Manufacturing Organizations
5. Global Biotechnology & Pharmaceutical Companies Cell Analysis Market Analysis and Forecast, by Therapeutic Area
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Market Value Forecast, by Therapeutic Area, 2015-2031
5.3.1. Oncology & Immune-oncology
5.3.1.1. Small Molecules
5.3.1.2. Protein-based Therapeutics
5.3.1.3. Cell Therapy
5.3.1.4. Nucleic Acid-based Drugs
5.3.2. Cardiovascular & Metabolic Diseases
5.3.2.1. Small Molecules
5.3.2.2. Protein-based Therapeutics
5.3.2.3. Cell Therapy
5.3.2.4. Nucleic Acid-based Drugs
5.3.3. Immunology
5.3.3.1. Small Molecules
5.3.3.2. Protein-based Therapeutics
5.3.3.3. Cell Therapy
5.3.3.4. Nucleic Acid-based Drugs
5.3.4. Rare Diseases
5.3.4.1. Small Molecules
5.3.4.2. Protein-based Therapeutics
5.3.4.3. Cell Therapy
5.3.4.4. Nucleic Acid-based Drugs
5.3.5. Neurological Diseases
5.3.5.1. Small Molecules
5.3.5.2. Protein-based Therapeutics
5.3.5.3. Cell Therapy
5.3.5.4. Nucleic Acid-based Drugs
5.3.6. Others
5.3.6.1. Small Molecules
5.3.6.2. Protein-based Therapeutics
5.3.6.3. Cell Therapy
5.3.6.4. Nucleic Acid-based Drugs
6. Global Biotechnology & Pharmaceutical Companies Cell Analysis Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2017-2031
6.3.1. Flow Cytometry
6.3.2. Image-based Cytometry
6.3.3. Biochemical Assays
6.3.4. Mass Spectrometry
7. Global Biotechnology & Pharmaceutical Companies Cell Analysis Market Analysis and Forecast, by Workplace
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Workplace, 2017-2031
7.3.1. Target Identification
7.3.2. Hit Generation & Lead Identification
7.3.3. Lead Optimization
7.3.4. In Vitro Preclinical Studies
7.3.5. In Vivo Preclinical Studies
7.3.6. Clinical Studies
8. Global Biotechnology & Pharmaceutical Companies Cell Analysis Market Analysis and Forecast, by Country/Region
8.1. Key Findings
8.2. Market Value Forecast, by Country/Region, 2017-2031
8.2.1. U.S.
8.2.2. Europe
8.2.3. China
8.2.4. Rest of the World
9. U.S. Cell Analysis Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by End-user, 2017-2031
9.2.1. Biotechnology & Pharmaceutical Companies
9.2.2. Academia
9.2.3. Cosmetic Industry
9.2.4. Contract Research Organizations
9.2.5. Contract Development and Manufacturing Organizations
9.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
9.3.1. Oncology & Immune-oncology
9.3.1.1. Small Molecules
9.3.1.2. Protein-based Therapeutics
9.3.1.3. Cell Therapy
9.3.1.4. Nucleic Acid-based Drugs
9.3.2. Cardiovascular & Metabolic Diseases
9.3.2.1. Small Molecules
9.3.2.2. Protein-based Therapeutics
9.3.2.3. Cell Therapy
9.3.2.4. Nucleic Acid-based Drugs
9.3.3. Immunology
9.3.3.1. Small Molecules
9.3.3.2. Protein-based Therapeutics
9.3.3.3. Cell Therapy
9.3.3.4. Nucleic Acid-based Drugs
9.3.4. Rare Diseases
9.3.4.1. Small Molecules
9.3.4.2. Protein-based Therapeutics
9.3.4.3. Cell Therapy
9.3.4.4. Nucleic Acid-based Drugs
9.3.5. Neurological Diseases
9.3.5.1. Small Molecules
9.3.5.2. Protein-based Therapeutics
9.3.5.3. Cell Therapy
9.3.5.4. Nucleic Acid-based Drugs
9.3.6. Others
9.3.6.1. Small Molecules
9.3.6.2. Protein-based Therapeutics
9.3.6.3. Cell Therapy
9.3.6.4. Nucleic Acid-based Drugs
9.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Technology, 2017-2031
9.4.1. Flow Cytometry
9.4.2. Image-based Cytometry
9.4.3. Biochemical Assays
9.4.4. Mass Spectrometry
9.5. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
9.5.1. Target Identification
9.5.2. Hit Generation & Lead Identification
9.5.3. Lead Optimization
9.5.4. In Vitro Preclinical Studies
9.5.5. In Vivo Preclinical Studies
9.5.6. Clinical Studies
10. Europe Cell Analysis Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by End-user, 2017-2031
10.2.1. Biotechnology & Pharmaceutical Companies
10.2.2. Academia
10.2.3. Cosmetic Industry
10.2.4. Contract Research Organizations
10.2.5. Contract Development and Manufacturing Organizations
10.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
10.3.1. Oncology & Immune-oncology
10.3.1.1. Small Molecules
10.3.1.2. Protein-based Therapeutics
10.3.1.3. Cell Therapy
10.3.1.4. Nucleic Acid-based Drugs
10.3.2. Cardiovascular & Metabolic Diseases
10.3.2.1. Small Molecules
10.3.2.2. Protein-based Therapeutics
10.3.2.3. Cell Therapy
10.3.2.4. Nucleic Acid-based Drugs
10.3.3. Immunology
10.3.3.1. Small Molecules
10.3.3.2. Protein-based Therapeutics
10.3.3.3. Cell Therapy
10.3.3.4. Nucleic Acid-based Drugs
10.3.4. Rare Diseases
10.3.4.1. Small Molecules
10.3.4.2. Protein-based Therapeutics
10.3.4.3. Cell Therapy
10.3.4.4. Nucleic Acid-based Drugs
10.3.5. Neurological Diseases
10.3.5.1. Small Molecules
10.3.5.2. Protein-based Therapeutics
10.3.5.3. Cell Therapy
10.3.5.4. Nucleic Acid-based Drugs
10.3.6. Others
10.3.6.1. Small Molecules
10.3.6.2. Protein-based Therapeutics
10.3.6.3. Cell Therapy
10.3.6.4. Nucleic Acid-based Drugs
10.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Technology, 2017-2031
10.4.1. Flow Cytometry
10.4.2. Image-based Cytometry
10.4.3. Biochemical Assays
10.4.4. Mass Spectrometry
10.5. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
10.5.1. Target Identification
10.5.2. Hit Generation & Lead Identification
10.5.3. Lead Optimization
10.5.4. In Vitro Preclinical Studies
10.5.5. In Vivo Preclinical Studies
10.5.6. Clinical Studies
10.6. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Country/Sub-region, 2017-2031
10.6.1. EU5
10.6.2. U.K.
10.6.3. Switzerland
10.6.4. Rest of Europe
11. China Cell Analysis Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by End-user, 2017-2031
11.2.1. Biotechnology & Pharmaceutical Companies
11.2.2. Academia
11.2.3. Cosmetic Industry
11.2.4. Contract Research Organizations
11.2.5. Contract Development and Manufacturing Organizations
11.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
11.3.1. Oncology & Immune-oncology
11.3.1.1. Small Molecules
11.3.1.2. Protein-based Therapeutics
11.3.1.3. Cell Therapy
11.3.1.4. Nucleic Acid-based Drugs
11.3.2. Cardiovascular & Metabolic Diseases
11.3.2.1. Small Molecules
11.3.2.2. Protein-based Therapeutics
11.3.2.3. Cell Therapy
11.3.2.4. Nucleic Acid-based Drugs
11.3.3. Immunology
11.3.3.1. Small Molecules
11.3.3.2. Protein-based Therapeutics
11.3.3.3. Cell Therapy
11.3.3.4. Nucleic Acid-based Drugs
11.3.4. Rare Diseases
11.3.4.1. Small Molecules
11.3.4.2. Protein-based Therapeutics
11.3.4.3. Cell Therapy
11.3.4.4. Nucleic Acid-based Drugs
11.3.5. Neurological Diseases
11.3.5.1. Small Molecules
11.3.5.2. Protein-based Therapeutics
11.3.5.3. Cell Therapy
11.3.5.4. Nucleic Acid-based Drugs
11.3.6. Others
11.3.6.1. Small Molecules
11.3.6.2. Protein-based Therapeutics
11.3.6.3. Cell Therapy
11.3.6.4. Nucleic Acid-based Drugs
11.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Technology, 2017-2031
11.4.1. Flow Cytometry
11.4.2. Image-based Cytometry
11.4.3. Biochemical Assays
11.4.4. Mass Spectrometry
11.5. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
11.5.1. Target Identification
11.5.2. Hit Generation & Lead Identification
11.5.3. Lead Optimization
11.5.4. In Vitro Preclinical Studies
11.5.5. In Vivo Preclinical Studies
11.5.6. Clinical Studies
12. Rest of the World Cell Analysis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by End-user, 2017-2031
12.2.1. Biotechnology & Pharmaceutical Companies
12.2.2. Academia
12.2.3. Cosmetic Industry
12.2.4. Contract Research Organizations
12.2.5. Contract Development and Manufacturing Organizations
12.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
12.3.1. Oncology & Immune-oncology
12.3.1.1. Small Molecules
12.3.1.2. Protein-based Therapeutics
12.3.1.3. Cell Therapy
12.3.1.4. Nucleic Acid-based Drugs
12.3.2. Cardiovascular & Metabolic Diseases
12.3.2.1. Small Molecules
12.3.2.2. Protein-based Therapeutics
12.3.2.3. Cell Therapy
12.3.2.4. Nucleic Acid-based Drugs
12.3.3. Immunology
12.3.3.1. Small Molecules
12.3.3.2. Protein-based Therapeutics
12.3.3.3. Cell Therapy
12.3.3.4. Nucleic Acid-based Drugs
12.3.4. Rare Diseases
12.3.4.1. Small Molecules
12.3.4.2. Protein-based Therapeutics
12.3.4.3. Cell Therapy
12.3.4.4. Nucleic Acid-based Drugs
12.3.5. Neurological Diseases
12.3.5.1. Small Molecules
12.3.5.2. Protein-based Therapeutics
12.3.5.3. Cell Therapy
12.3.5.4. Nucleic Acid-based Drugs
12.3.6. Others
12.3.6.1. Small Molecules
12.3.6.2. Protein-based Therapeutics
12.3.6.3. Cell Therapy
12.3.6.4. Nucleic Acid-based Drugs
12.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Technology, 2017-2031
12.4.1. Flow Cytometry
12.4.2. Image-based Cytometry
12.4.3. Biochemical Assays
12.4.4. Mass Spectrometry
12.5. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
12.5.1. Target Identification
12.5.2. Hit Generation & Lead Identification
12.5.3. Lead Optimization
12.5.4. In Vitro Preclinical Studies
12.5.5. In Vivo Preclinical Studies
12.5.6. Clinical Studies

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings